Size is one of the decisive characteristics of liposomes for advanced chemotherapy of tumors. Larger sized liposomes are effectively taken up by the reticuloendothelial system (RES) and cleared from ...

Liposomal encapsulation of anticancer drugs has been pursued intensively during the past number of years. This pharmaceutical strategy offers the theoretical advantage of increasing drug efficiency ...

Cancer is a life-threatening disease, leading to millions of fatalities every year. While advances in medical science have improved the prognosis significantly in the 21st century, it is still one of ...

Ipsen (Euronext: IPN; ADR: IPSEY) and Servier announced today initial safety and efficacy data from Part 1 of the Phase II/III RESILIENT study of investigational liposomal irinotecan (ONIVYDE®) in ...

Breast carcinoma is the most frequent cancer, and the second most leading cause of death from cancer in women (Jemal et al, 2007). Approximately 27% of patients are initially diagnosed with already ...

Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420 Although all authors completed the disclosure declaration ...

This large trial was for ovarian cancer that had come back after prior chemotherapy that included a platinum drug. It was comparing liposomal doxorubicin alone with the combination of liposomal ...

New York, Dec. 16, 2021 (GLOBE NEWSWIRE) -- According to the new market research report "Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Liposomal ...

Pegylated liposomal irinotecan (Onivyde, Shire) consists of the anticancer drug irinotecan contained within tiny fat particles called nanoliposomes. The nanoliposomes accumulate in the tumour and ...

The Department of Health has asked the National Institute of Health and Care Excellence (NICE) to produce guidance on using topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, ...

Liposomes are well-established nanocarriers for improving the therapeutic index of anticancer agents. A remarkable understanding in the pathophysiology of breast cancer progression has emerged with ...